Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Probiotic infant formula: Nestle Good Start Natural Cultures is the "first and only" U.S. infant formula with probiotics that help support a healthy immune system, Nestle Nutrition announces April 30. Launching now, the formula is designed to help supplement-fed infants achieve higher levels of beneficial bacteria, improving the balance of microflora in the gastrointestinal tract and supporting a healthy immune system, the firm notes. In addition to beneficial bacterial, the formula contains whey protein and DHA and ARA for brain and eye development. Natural Cultures is available in Wal-Mart, Target, Babies R Us and other retailers and will rollout nationwide in July. The formula comes in 12 oz. and 24 oz. sizes for $13.99 and $26.99, respectively. Ads supporting the launch are breaking in medical journals and consumer ads and will run later in the year. Nestle recently announced a deal to create probiotic-containing infant products targeting respiratory tract infections (1"The Tan Sheet" April 16, 2007, Research & Development In Brief)...

You may also be interested in...



Research & Development In Brief

Nestle eyes infant probiotic products: Nestle Nutrition is looking to launch probiotic-containing infant nutrition products targeting upper respiratory tract infections, according to an agreement announced March 28. New Zealand biotech firm BLIS Technologies has agreed to work exclusively with the Nestle SA division to carry out the research and development of probiotics "suitable for incorporation into infant nutrition products," the company says. "If the project proceeds according to plan, the company will commit significant resources to the development over the next three years," BLIS says. The probiotic helps provide protection against Streptococcus pyogenes, BLIS says, adding that the agreement should enable it to "build a platform of probiotics with significant market opportunities." This is not Nestle's first foray into infant probiotics (1"The Tan Sheet" Jan. 29, 2007, In Brief)...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS100482

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel